Use of nonlinear mixed-effects analysis for improved precision of early pharmacodynamic measures in tuberculosis treatment

被引:50
作者
Davies, Geraint R.
Brindle, Richard
Khoo, Saye H.
Aarons, Leon J.
机构
[1] Univ Liverpool, Wellcome Trust Ctr Clin Trop Med, Liverpool L69 3BX, Merseyside, England
[2] Portsmouth Hosp, Dept Clin Microbiol, Portsmouth, Hants, England
[3] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England
[4] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester, Lancs, England
基金
英国惠康基金;
关键词
D O I
10.1128/AAC.00774-05
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Nonlinear mixed-effects analysis of serial sputum colony-counting data supports the existence of two bacillary subpopulations in sputum, eliminated at different rates. It distinguishes between combination regimens, removes bias, and greatly improves precision, with significant implications for the analysis of surrogate endpoints of "sterilization" in the development of new antituberculosis regimens.
引用
收藏
页码:3154 / 3156
页数:3
相关论文
共 21 条
[1]   Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis [J].
Brindle R. ;
Odhiambo J. ;
Mitchison D. .
BMC Pulmonary Medicine, 1 (1)
[2]   QUANTITATIVE BACILLARY RESPONSE TO TREATMENT IN HIV-ASSOCIATED PULMONARY TUBERCULOSIS [J].
BRINDLE, RJ ;
NUNN, PP ;
GITHUI, W ;
ALLEN, BW ;
GATHUA, S ;
WAIYAKI, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04) :958-961
[3]   Evaluation of sputum decontamination methods for Mycobacterium tuberculosis using viable colony counts and flow cytometry [J].
Burdz, TVN ;
Wolfe, J ;
Kabani, A .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 47 (03) :503-509
[4]  
Canetti G, 1955, TUBERCLE BACILLUS PU
[5]  
Davidian M., 1995, NONLINEAR MODELS REP
[6]   Localisation of mycobacterial DNA and mRNA in human tuberculous granulomas [J].
Fenhalls, G ;
Stevens-Muller, L ;
Warren, R ;
Carroll, N ;
Bezuidenhout, J ;
Van Helden, P ;
Bardin, P .
JOURNAL OF MICROBIOLOGICAL METHODS, 2002, 51 (02) :197-208
[7]  
Fox W, 1999, INT J TUBERC LUNG D, V3, pS231
[8]   A reiterative method for calculating the early bactericidal activity of antituberculosis drugs [J].
Gillespie, SH ;
Gosling, RD ;
Charalambous, BM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :31-35
[9]  
*GLOB ALL TB DRUG, 2001, TUBERCULOSIS EDIN S1, V81
[10]  
JINDANI A, 1980, AM REV RESPIR DIS, V121, P939